mTOR has additionally been implicated in several other processes that are impaired in AD, meaning that mTOR dysregulation may represent a mechanism of AD which targets a broad range of systems disrupted in the disease (Hoeffer et al., 2008; Oddo, 2012; Huang et al., 2013). The gene discussed is MTOR; the disease is Alzheimer disease.